Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 160

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose‐lowering agents

Hauber, A. B., Mohamed, A. F., Johnson, F. R., Falvey, H.·2009·Diabetic Medicine

Abstract

Aims Medication non‐adherence is particularly common in patients with Type 2 diabetes. We constructed a discrete‐choice experiment to examine the relative importance of oral glucose‐lowering medication features and to estimate the likely effect of effectiveness and side effects on medication adherence in patients with Type 2 diabetes in the UK and the USA. Methods Preferences were elicited using a cross‐sectional, web‐enabled survey. Patients with a self‐reported physician‐made diagnosis of Type 2 diabetes, who were currently taking oral glucose‐lowering medications were recruited through an existing online chronic‐disease panel. In each discrete‐choice question, patients were asked to choose between two hypothetical medication alternatives, each defined by improvement in glycated haemoglobin, frequency of mild‐to‐moderate hypoglycaemia, water retention, weight gain, mild stomach upset and medication‐related cardiovascular risk. Patients were also asked to indicate how likely they would be to miss or skip doses of each hypothetical medication. Results Two hundred and four patients in the UK and 203 patients in the USA completed the survey. Preferences did not differ between the two countries. Overall, glucose control was the most important medication feature, followed by medication‐related cardiovascular risk and weight gain, respectively. Water retention was not important to patients. Weight gain and cardiovascular risk had significant negative effects on likely medication adherence. Conclusions While patients with Type 2 diabetes believe glucose control is important, medication side effects and risks influence patients’ treatment choices. Medication‐related weight gain and cardiovascular risk are significant predictors of likely medication non‐adherence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2009.02696.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 160

Metadata

Authors
Hauber, A. B., Mohamed, A. F., Johnson, F. R., & Falvey, H.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2009-04
Volume
26
Issue
4
Pages
416-424
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2086588588
Cited by
160
References
3
FWCI
8.84
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose‐lowering agents. https://app.cochat.ai/papers/10.1111/j.1464-5491.2009.02696.x
The paper
Hauber, A. B., Mohamed, A. F., Johnson, F. R., & Falvey, H. (2009). Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose‐lowering agents. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2009.02696.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.